The Seraph 100

COVID-19 SARS-CoV-2 Seraph 100 antibodies mucosal

Journal

Antibodies (Basel, Switzerland)
ISSN: 2073-4468
Titre abrégé: Antibodies (Basel)
Pays: Switzerland
ID NLM: 101587489

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 31 05 2024
revised: 13 07 2024
accepted: 01 08 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: epublish

Résumé

PURIFY-OBS-1 is an observational study evaluating the safety and efficacy of Seraph 100

Identifiants

DOI: 10.3390/antib13030065 PMID: 39189236
pubmed: 39189236
pii: antib13030065
doi: 10.3390/antib13030065
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Tonia L Conner (TL)

Department of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
ORCID: 0009-0004-1617-1231

Pooja Vir (P)

The Henry Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20814, USA.
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

Eric D Laing (ED)

Department of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
ORCID: 0000-0002-5574-2584

Ian J Stewart (IJ)

Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

Edward Mitre (E)

Department of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

Kathleen P Pratt (KP)

Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
ORCID: 0000-0001-6837-6133

Classifications MeSH